1. Academic Validation
  2. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein

Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein

  • EMBO J. 2001 Dec 17;20(24):7184-96. doi: 10.1093/emboj/20.24.7184.
I Kitabayashi 1 Y Aikawa L A Nguyen A Yokoyama M Ohki
Affiliations

Affiliation

  • 1 Cancer Genomics Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. [email protected]
Abstract

The AML1-CBF beta transcription factor complex is the most frequent target of specific chromosome translocations in human leukemia. The MOZ gene, which encodes a Histone Acetyltransferase (HAT), is also involved in some leukemia-associated translocations. We report here that MOZ is part of the AML1 complex and strongly stimulates AML1-mediated transcription. The stimulation of AML1-mediated transcription is independent of the inherent HAT activity of MOZ. Rather, a potent transactivation domain within MOZ appears to be essential for stimulation of AML1-mediated transcription. MOZ, as well as CBP and MOZ-CBP, can acetylate AML1 in vitro. The amount of AML1-MOZ complex increases during the differentiation of M1 myeloid cells into monocytes/macrophages, suggesting that the AML1-MOZ complex might play a role in cell differentiation. On the other hand, the MOZ-CBP fusion protein, which is created by the t(8;16) translocation associated with acute monocytic leukemia, inhibits AML1-mediated transcription and differentiation of M1 cells. These results suggest that MOZ-CBP might induce leukemia by antagonizing the function of the AML1 complex.

Figures